About the role
As a Software Engineer at TRI, you will be working in a growing engineering team that focuses on the design, build and maintenance of TRI’s web and software applications that support clinical trials. You will also support, mentor and coach more junior members of the team.
We use an Agile approach to development, so in your Scrum Team you will work with Engineering, Product and Test colleagues to gain an understanding of product requirement, technical strategies and testing implications. You will work with the Lead Software Engineer, Product Owner, and other engineers to create effort and time estimations for User and Tech Stories.
You’ll use your engineering skills to design, build and maintain scalable reliable, and secure web and software applications. You’ll be keen to keep up to date with the latest technologies, and to contribute new ideas to the business.
Part of the Software Engineer role is to support and mentor more junior members of the engineering team, sharing your skills and experience to help the whole team develop in a cohesive and collaborative way.
Our company culture
At TRI, we take pride in our open and collaborative company culture – it’s at the heart of everything we do. Our aim is to support each other and set each other up for success.
As a TRI team member, you can expect to be offered the right environment, compensation, and development opportunities to allow you to focus on being successful, and to support your colleagues to do the same.
In return, TRI expects our team members to work hard, focusing on what really matters. We ask for honesty, thoughtful communication, and cross-functional support. It really is that simple.
About OPRA (Operational Platform for Review and Analytics)
OPRA is smart software, built specifically for better risk management in clinical trials. It’s ‘spreadsheet easy’, but much more powerful, which mean our clients achieve better data quality, and increased efficiency.
Risk Based Quality Management (RBQM) is a methodology for ensuring that clinical trial data is of the highest quality and integrity. This means proactively identifying, assessing, and managing trial risks – which is where OPRA comes in.
Ultimately, using OPRA leads to safer patients and happier clinical trials teams – with the end goal being higher quality trials, leading to better drugs getting to market quicker and saving more lives. What’s more important than that?
About us
At TRI, our mission is to make Risk-Based Quality Management simple; making it accessible, understandable, and actionable for clinical trials of any scale and complexity. We develop innovative technologies and simplified solutions to empower research organizations and sponsors, ensuring the highest standards of trial integrity and participant safety.
Our History!
2013
Establishing our foundation in Cambridge, UK
TRI marked its entry into the world of clinical trial quality management by opening our first office in the historic and intellectually vibrant city of Cambridge. This milestone symbolized our commitment to innovation and excellence, setting the stage for a future where research and technology converge to redefine industry standards.
2016
Introducing OPRA, a new era of monitoring
Our journey took a significant leap forward in 2016 with the launch of OPRA-CM, our centralized monitoring platform. Designed with precision and user experience in mind, OPRA-CM revolutionized how research data is monitored, ensuring higher quality, efficiency, and compliance in clinical trials. This innovation underscored our dedication to transforming research methodologies through smart technology.
2020
Further advancing risk management
In 2020, TRI once again pushed the boundaries of quality management by unveiling our advanced risk assessment and management tool, OPRA-RAM. This tool was developed to empower researchers to proactively identify, evaluate, and mitigate risks in their studies, ensuring the utmost integrity and reliability of research outcomes. This launch not only highlighted our ongoing commitment to safety and excellence but also set new benchmarks in research risk management.